MELINTA THERAPEUTICS, INC. Uncategorized Contracts & Agreements
18 Contracts & Agreements
- Restructuring Support Agreement, dated December 27, 2019, by and between the Debtors and the Supporting Lenders (Filed With SEC on December 27, 2019)
- Debt Commitment Letter, dated December 18, 2018, by and among Melinta Therapeutics, Inc., Vatera Healthcare Partners LLC and Vatera Investment Partners LLC (Filed With SEC on December 19, 2018)
- Commitment Letter, dated November 6, 2018, by and between Melinta Therapeutics, Inc. and Vatera Healthcare Partners LLC (Filed With SEC on November 7, 2018)
- Side Letter Agreement with Daniel Mark Wechsler, dated October 23, 2018 (Filed With SEC on October 24, 2018)
- Form of Option Agreement (Filed With SEC on June 14, 2018)
- Form of Option Agreement (Filed With SEC on June 14, 2018)
- Letter Agreement, dated as of February 5, 2016, by and between Melinta Therapeutics, Inc. and John Temperato (Filed With SEC on March 14, 2018)
- Letter Agreement, dated as of December 2, 2001, by and between Melinta Therapeutics, Inc. and Erin Duffy (Filed With SEC on March 14, 2018)
- Letter Agreement, dated November 18, 2013, by and between Melinta Therapeutics, Inc. and Sue Cammarata (Filed With SEC on March 14, 2018)
- Letter Agreement, dated November 8, 2013, as amended, by and between Melinta Therapeutics, Inc. and Paul Estrem, as amended and restated on March 16, 2015 (Filed With SEC on March 14, 2018)
- Royalty Agreement, dated January 5, 2018, between Melinta Therapeutics, Inc. and Deerfield Private Design Fund IV, L.P., Deerfield Private Design Fund III, L.P., and Deerfield... (Filed With SEC on January 9, 2018)
- Letter, dated November 28, 2017, by and between Deerfield Private Design Fund IV, L.P. and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Letter, dated November 28, 2017, by and between JWC Rib-X LLC and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- Letter, dated November 28, 2017, by and between Vatera Healthcare Partners LLC and Melinta Therapeutics, Inc (Filed With SEC on December 1, 2017)
- CEMPRA, INC. $150,000,000 SALESAGREEMENT (Filed With SEC on May 6, 2016)
- Portions of this exhibit marked [*] are requested to be treated confidentially. (Filed With SEC on August 8, 2012)
- CEMPRA, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CUSIP NUMBER 15130J 109 (Filed With SEC on December 22, 2011)
- CEMPRA HOLDINGS, LLC PLAN OF CONVERSION (Filed With SEC on October 12, 2011)
